Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CRL✓SelectedUSD · CRLGSK vs CRL performance historyLatest closeAs of-1.34%11/18
Stock and ETF performance explorer

GSK vs CRL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+42.8%
CRL return
-15.5%
Excess return
+58.3%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCRLExcessAlpha
1D-1.3%+0.3%-1.7%-1.4%
7D-3.1%-2.8%-0.4%-2.9%
30D-0.9%+11.1%-12.0%-2.3%
3M-4.2%+19.4%-23.5%-6.4%
6M-1.6%+122.3%-123.9%-10.5%
YTD+2.6%+67.1%-64.5%-4.2%
1Y+6.2%+105.0%-98.8%-3.2%
3Y+55.0%+76.3%-21.3%+40.3%
5Y+42.8%-14.0%+56.8%+36.9%
All+42.8%-15.5%+58.3%+36.9%

Cumulative growth

Daily Returns

Daily percentage return beside CRL.

Daily Out/Under-Performance

Portfolio return minus CRL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CRL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CRL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling